Qijie Ran
Wuhan, 430070, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High expression of polo-like kinase 4 predicts worse progression-free survival in diffuse large B cell lymphoma patients treated with R-CHOP.
Journal: World journal of surgical oncology
Published: May 23, 2025
Circular RNA_0003489 reflects unfavorable treatment response and shortened survival in newly diagnosed multiple myeloma patients who receive bortezomib-based induction therapy.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 13, 2024
Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradation.
Journal: Journal of hematology & oncology
Published: June 22, 2024
Comparison on the clinical characteristics of patients with Takotsubo syndrome from China and from Europe/North America
Journal: Zhonghua xin xue guan bing za zhi
Published: April 11, 2022
PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling.
Journal: Irish journal of medical science
Published: February 17, 2022
Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA.
Journal: Frontiers in oncology
Published: December 15, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026